Douglas Melton

Douglas Melton discloses dealings in 2 companies, chiefly bluebird bio, Inc. and Curis Inc. We count 6 filings; the first trade dates from 1 June 2006 and the latest from 18 June 2020.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 22 June 2020, the filings show a share grant in bluebird bio, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.